Make an inquiry
Refer a patient
833 367-6942
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
833 367-6942
Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
833 367-6942
Healthcare Professionals
Latest research
Publications
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.
01 Aug 2021
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.
written by
Shore Neal D., MD, FACS,
Susan Halabi, Shan Jiang, Emi Terasawa, Viviana Garcia-Horton, Rajeev Ayyagari, A. Reginald Waldeck, and Neal Shore
Back to top
